Keywords

• Clopidogrel Bisulfate
• GMP/COS Clopidogrel Bisulfate
• Clopidogrel Bisulfate factory

Quick Details

• ProName: Clopidogrel Bisulfate biggerst supplie...
• CasNo: 120202-66-6
• Molecular Formula: C16H16ClNO2S.H2SO4
• Appearance: white powder
• Application: Used in Synthesis, Pharmaceuticals
• DeliveryTime: within 7 days
• PackAge: bag or carton
• Port: xingang
• ProductionCapacity: 100 Kilogram/Day
• Purity: 99%
• Storage: Store in dry, dark and ventilated plac...
• Transportation: sea air
• LimitNum: 1 Kilogram

Superiority

• ProName: Clopidogrel Bisulfate biggerst supplie...
• CasNo: 120202-66-6
• Molecular Formula: C16H16ClNO2S.H2SO4
• Appearance: White powder
• Application: API
• DeliveryTime: as soon as possible after payment
• PackAge: 20kg fiber drum
• ProductionCapacity: 50 Metric Ton/Year
• Purity: 99.9%
• Storage: Store in dry and cool place.
• Transportation: by air or by sea

Details

tianma established in 1993 in suzhou china, we are the leading manufacturers of:

• advanced intermediates
• apis
• nutritions
• peptide related chemicals
• phosgene & nacn derivatives
• specialty chemicals synthetic

in order to offer the best contract manufacture service to customers, tianma sets up one r&d center and seven production sites around china. the main business of tianma not only contains pharmaceutical and chemical, but also expand to nutrition, real estate and hotel chain.

clopidogrel is an inhibitor of platelet aggregation; doses of 75 mg per day inhibit platelet aggregation by 40 to 60% at steady state, which occurs within 3 to 7 days.

clopidogrel inhibits adenosine diphosphate (adp) binding to its platelet receptor and subsequent adp-mediated activation of the glycoprotein gpiib/iiia complex, thus inhibiting platelet aggregation. because clopidogrel irreversibly modifies the adp receptor, platelets are affected for the remainder of their lifespan. an active metabolite, not yet isolated, is responsible for the medication's activity. platelet aggregation induced by agonists other than adp is also inhibited by blocking the amplification of platelet activation by released adp. clopidogrel does not inhibit phosphodiesterase activity.